CA
CHI Advisors Portfolio holdings
AUM
$252M
This Quarter Return
+7.66%
1 Year Return
+57.46%
3 Year Return
+78.52%
5 Year Return
–
10 Year Return
–
AUM
$500M
AUM Growth
+$500M
(+41%)
Cap. Flow
+$162M
Cap. Flow
% of AUM
32.47%
Top 10 Holdings %
Top 10 Hldgs %
91.39%
Holding
24
New
3
Increased
6
Reduced
11
Closed
2
Top Buys
Top Sells
| 1 |
American Well
AMWL
|
$6.29M |
| 2 |
Ovid Therapeutics
OVID
|
$2.33M |
| 3 |
Keros Therapeutics
KROS
|
$2.05M |
| 4 |
Precision BioSciences
DTIL
|
$1.66M |
| 5 |
INZY
Inozyme Pharma
INZY
|
$1.35M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cullinan Oncology
CGEM
$445M
| $91.8M | 18.37% | +2,202,407 | New | +$91.8M |
|
2
Pliant Therapeutics
PLRX
$101M
| $91.4M | 18.3% | 2,324,795 -30,004 | -1% | -$1.18M |
|
3
Repare Therapeutics
RPTX
$71.7M
| $78.6M | 15.73% | 2,560,703 +28,553 | +1% | +$876K |
|
|
RXDX
4
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $52.5M | 10.51% | +2,874,032 | New | +$52.5M |
|
|
ORTX
5
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $29.4M | 5.89% | 4,051,972 +1,120,787 | +38% | +$8.14M |
|
|
ONCR
6
DELISTED
Oncorus, Inc.
ONCR
| $24.7M | 4.94% | 1,771,786 +91,880 | +5% | +$1.28M |
|
|
7
Keros Therapeutics
KROS
$618M
| $24.6M | 4.93% | 400,468 -33,384 | -8% | -$2.05M |
|
|
IMA
8
ImageneBio, Inc. Common Stock
IMA
$150M
| $23M | 4.61% | +814,756 | New | +$23M |
|
9
Larimar Therapeutics
LRMR
$310M
| $22.1M | 4.43% | 1,515,148 | – | – |
|
|
INZY
10
DELISTED
Inozyme Pharma
INZY
| $18.4M | 3.68% | 927,264 -68,132 | -7% | -$1.35M |
|
|
FRLN
11
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
| $17M | 3.41% | 1,384,743 +23,679 | +2% | +$291K |
|
|
AKUS
12
DELISTED
Akouos, Inc. Common Stock
AKUS
| $11.9M | 2.38% | 858,027 -12,870 | -1% | -$179K |
|
|
13
Precision BioSciences
DTIL
$57.8M
| $7.16M | 1.43% | 691,629 -160,729 | -19% | -$1.66M |
|
14
Corvus Pharmaceuticals
CRVS
$428M
| $2.09M | 0.42% | 679,132 +188,255 | +38% | +$580K |
|
|
GTHX
15
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.2M | 0.24% | 50,000 -12,000 | -19% | -$289K |
|
16
Kezar Life Sciences
KZR
$28.9M
| $1.04M | 0.21% | 174,169 +39,169 | +29% | +$233K |
|
|
17
Ovid Therapeutics
OVID
$91M
| $995K | 0.2% | 247,510 -579,750 | -70% | -$2.33M |
|
|
GBT
18
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $611K | 0.12% | 15,000 -7,800 | -34% | -$318K |
|
19
Adverum Biotechnologies
ADVM
$64.6M
| $396K | 0.08% | 40,209 -19,000 | -32% | -$187K |
|
|
BPMC
20
DELISTED
Blueprint Medicines
BPMC
| $340K | 0.07% | 3,500 -2,000 | -36% | -$194K |
|
21
Ultragenyx Pharmaceutical
RARE
$2.89B
| $228K | 0.05% | 2,000 -1,000 | -33% | -$114K |
|
|
22
American Well
AMWL
$111M
| – | – | -248,352 | Closed | -$6.29M |
|
|
BLUE
23
DELISTED
bluebird bio
BLUE
| – | – | -8,000 | Closed | -$346K |
|
24
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – | 0 | – | – |
|